Market Overview
The Global Cell Culture Market is expected to reach a value of
USD 28.2 billion in 2023, and it is further anticipated to reach a market value of
USD 69.7 billion by 2032 at a
CAGR of 10.6%.
Cell culture includes cultivating cells in a controlled environment, typically outside their natural surroundings. Cells of interest are isolated from living tissue & can thrive under these controlled conditions, which allows for the sustained growth & study of cells outside their native environment, providing researchers with a valuable tool for different applications in biomedical research & biotechnology.
Key Takeaways
• By Product, Consumables leads in 2023 & is anticipated to dominate throughout the forecasted period.
• In addition, Instruments is expected to have significant growth over the forecasted period.
• By Application, Drug Discovery takes the lead & drives the market in 2023
• North America has a 37.0% share of revenue in the Global Cell Culture Market in 2023
Market Dynamic
The global demand for vaccines has increased due to the threat of virus outbreaks, prompting the pharmaceutical industry to look for highly efficient vaccine variants, as the cell culture has become a cornerstone in vaccine development, finding application in creating vaccines for various diseases. Further, developed nations exhibit a growing preference for cell-based vaccines, streamlining regulatory approval processes, as the awareness of the numerous benefits offered by cell culture vaccines is also on the rise.
However, market growth faces challenges, like the high costs associated with R&D, limited infrastructure in certain regions, expensive medicines, & inadequate awareness in less economically advanced economies. Also, challenges arise from unfavorable reimbursement scenarios, limited technology penetration in developing nations, high customs duties on medical devices, & inadequate infrastructure in low- and middle-income countries, creating hurdles for the market in the forecast period.
Research Scope and Analysis
By Product
In terms of product, the consumables segment holds the largest market share in 2023 and is anticipated to experience significant growth in the forecast period, driven by the constant demand for consumables and increased R&D spending by biotechnology & biopharmaceutical companies, with increased investment, aims to develop advanced biologics, like monoclonal antibodies & vaccines, further boosting the consumption of consumables. The consumables segment includes reagents, media, and sera, all of which are expected to maintain high demand.
Moreover, within the consumables segment, the cell culture media category claimed the largest share in 2023, due to the surge in R&D investments, the expansion of life sciences industries, mainly in biopharmaceutical products, & the overall growth of the biotechnology sector. In addition, the growing interest in stem cells & their expanding applications in biotechnological research are significant contributors to the expanding market for cell culture media.
By Application
The global cell culture market is led by the biopharmaceuticals segment in 2023, driven by the vast use of mammalian cell cultures in developing pharmaceuticals & the higher demand for genetically & proteomically improved medicines. Further, the effectiveness of biopharmaceuticals in treating various diseases has contributed to their popularity among patients, driving segment growth. Also, the surge in R&D activities in biopharmaceuticals has increased the demand for cell culture techniques, mainly among contract researchers & manufacturers who highly adopt third-party services.
Furthermore, the most promising segment in the forecast period is drug discovery, responding to the growth in the need for innovative drugs owing to the prevalence of chronic & genetic diseases. As cell-based research studies, integral to drug discovery, have experienced an evolution from 2D to 3D culture techniques, developing accuracy in high-throughput screening. Increased investments by biopharmaceutical companies in drug discovery processes to develop novel therapies & vaccines are anticipated to propel the growth of the drug discovery segment in the cell culture market.
By End User
Pharmaceutical & biotechnology companies stand as crucial end-users in the Cell Culture Market by driving the growth of the overall market in 2023. These industries highly utilize cell culture technologies for different applications, like drug development, vaccine production, & biopharmaceutical manufacturing. Further, the need for cell culture techniques are highly used in pharmaceutical and biotech companies due to their dependency on precise & controlled environments for cultivating cells, tissues, and microorganisms. The market to the specific needs of these companies facilitates the growth of cells for research and large-scale production of therapeutic products.
In addition, in the pharmaceutical & biotechnology sectors, the adoption of advanced cell culture technologies is vital for improving research capabilities & optimizing the production of biologics. The industry's constant desire for new drugs, vaccines, & biopharmaceuticals requires sophisticated cell culture methodologies, making these companies key contributors to the market's growth.
The Cell Culture Market Report is segmented on the basis of the following:
By Product
• Consumables
• Instruments
By Application
• Drug Discovery
• Biopharmaceuticals
• Tissue Culture and Engineering
• Vaccine Production
• Gene Therapy
• Others
By End User
• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostic Laboratories
• Research & Academic Institutes
• Other
Regional Analysis
North America dominates the market with a significant 37.0% share in 2023, mainly due to the well-established pharmaceutical & biotech sectors, along with broad usage of technologically developed in the US. Further, the region also benefits from a strong market for cell culture technologies, driven by vast cell therapy research undertaken by different universities as the need for such technologies in both research & clinical applications is further driven by the increasing number of chronic & infectious diseases in the region.
Moreover, the Asia Pacific region is expected to have rapid expansion, projected to be the fastest-growing market over the forecast period, which is fueled by increased healthcare expenditure, growing awareness of cell & gene therapies, and a high potential for clinical research applications. The adoption of scientific technologies & emerging therapeutics, like regenerative medicines and cancer immunotherapies, is anticipated to further boost the region's growth in the coming years.
By Region
North America
• The U.S.
• Canada
Europe
• Germany
• The U.K.
• France
• Italy
• Russia
• Spain
• Benelux
• Nordic
• Rest of Europe
Asia-Pacific
• China
• Japan
• South Korea
• India
• ANZ
• ASEAN
• Rest of Asia-Pacific
Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of Latin America
Middle East & Africa
• Saudi Arabia
• UAE
• South Africa
• Israel
• Egypt
• Rest of MEA
Competitive Landscape
The cell culture market experiences moderate competition with a focus on several key players. A few major companies currently hold significant market share. Further, the ongoing competition is intensified by constant advancements & enhancement in cell culture platforms introduced by these major players, emphasizing the dynamic and evolving nature of the market.
In July 2023, Merck made a major investment of about USD 25.85 million in Kansas, USA, to expand the production capacity for cell culture media, which highlights Merck's commitment to meeting the growing demand for cell culture media & reflects the company's dedication to improving its capabilities in the development &manufacturing of essential biopharmaceutical components.
Some of the prominent players in the global Cell Culture Market are:
• Merck KGaA
• Corning Incorporated
• Lonza
• FUJIFILM Irvine
• VWR International
• BioSpherix Ltd
• BD
• Avantor
• PromoCell
• Thermo Fisher Scientific
• Other Key Players
COVID-19 Pandemic & Recession: Impact on the Global Cell Culture Market:
The global cell culture market faced major challenges during the COVID-19 pandemic &subsequent recession. The initial disruptions included supply chain issues, lockdowns impacting laboratory operations, & delays in clinical trials, impacting market growth. However, the pharmaceutical industry's increased focus on vaccine development & therapeutic research created a growth in demand for cell culture products, which along with increased funding for biopharmaceutical advancements, served as a counterforce, contributing to market resilience. As economies gradually recover, the cell culture market is expected to expand, driven by ongoing R&D activities, rising demand for biologics, and the continuous pursuit of innovative therapies.
Recent Development
• In February 2022, Nucleus Biologics introduced Krakatoa, an inventive media maker, one of the first in the market, designed to help researchers produce cell culture media directly at the point of use, which offers a streamlined solution, allowing researchers to create customized cell culture media with efficiency & convenience, marking a major advancement in laboratory practices.
• In February 2022, KromaTiD announced an extensive suite of services covering cell & blood culture growth, isolation, processing, and & control, as these offerings not only enrich the company's portfolio but also contribute to the growing demand for cell culture products & consumables, thus playing a vital role in driving the overall growth of the market.
• In June 2022, Evonik introduced the cQrex portfolio, a range of cell culture ingredients focused on enhancing efficiency and productivity in bioprocesses., which is designed to optimize the production of monoclonal antibodies, vaccines, viral vectors, & therapeutic cells. With the cQrex portfolio, the company aims to provide valuable solutions that contribute to advancing bioprocessing capabilities for various essential applications in the healthcare & biopharmaceutical industries.
Report Characteristics |
Market Size (2023) |
USD 28.2 Bn |
Forecast Value (2032) |
USD 69.7 Bn |
CAGR (2023-2032) |
10.6% |
Historical Data |
2017 - 2022 |
Forecast Data |
2023 - 2032 |
Base Year |
2022 |
Estimate Year |
2023 |
Report Coverage |
Market Revenue Estimation, Market Dynamics, Competitive Landscape, Growth Factors and etc. |
Segments Covered |
By Product (Consumables and Instruments), By
Application (Drug Discovery, Biopharmaceuticals,
Tissue Culture and Engineering, Vaccine Production,
Gene Therapy, and Others), By End User
(Pharmaceutical & Biotechnology Companies,
Hospitals & Diagnostic Laboratories, Research &
Academic Institutes, and Other) |
Regional Coverage |
North America – The US and Canada; Europe – Germany, The UK, France, Russia, Spain, Italy, Benelux, Nordic, & Rest of Europe; Asia- Pacific– China, Japan, South Korea, India, ANZ, ASEAN, Rest of APAC; Latin America – Brazil, Mexico, Argentina, Colombia, Rest of Latin America; Middle East & Africa – Saudi Arabia, UAE, South Africa, Turkey, Egypt, Israel, & Rest of MEA
|
Prominent Players |
Merck KGaA, Corning Incorporated, Lonza, FUJIFILM
Irvine, VWR International, BioSpherix Ltd, BD,
Avantor, PromoCell, Thermo Fisher Scientific, and
Other Key Players |
Purchase Options |
We have three licenses to opt for: Single User License (Limited to 1 user), Multi-User License (Up to 5 Users), and Corporate Use License (Unlimited User) along with free report customization equivalent to 0 analyst working days, 3 analysts working days and 5 analysts working days respectively. |
Frequently Asked Questions
The Global Cell Culture Market size is estimated to have a value of USD 28.2 billion in 2023 and is
expected to reach USD 69.7 billion by the end of 2032.
North America has the largest market share for the Global Hospital Asset Management Market with a
share of about 37.0% in 2023.
Some of the major key players in the Global Cell Culture Market are Merck KGaA, Corning Incorporated,
Lonza, and many others.
The market is growing at a CAGR of 10.6 percent over the forecasted period.